Total Voting Rights - Replacement

RNS Number : 7548K

GlaxoSmithKline PLC

04 January 2016

 

The following announcement replaces the 'Total Voting Rights and Capital' announcement released on 4 January 2016 at 10.56am under RNS No 7138K.

The full amended text is shown below.

GlaxoSmithKline plc

Total Voting Rights and Capital

In conformity with Disclosure and Transparency Rule ('DTR') 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:

The Company's issued share capital as at 31 December 2015 consisted of 5,361,307,647 Ordinary Shares of 25p each, of which 491,515,950 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 4,869,791,697. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For the purposes of DTR 6.4.2R, the Home State of GlaxoSmithKline plc is the United Kingdom.

V A Whyte

Company Secretary

4 January 2016

 

END

 

 

TVRAKQDBQBKDPDK